BCMA, i.e., CD269 or TNFRSF17, is a TNF receptor superfamily 17 member, expressed on differentiated plasma cells and plasmablasts under physiological conditions and nearly on all MM tumor cells[29-31]. This evidence concerns the gene TNFRSF17 and Miyoshi myopathy.